Crossmark

Next-generation antibody-based therapeutics in cancer: antibody-drug conjugates bispecific antibodies across hematologic malignancies and solid tumors

Crossref DOI link: https://doi.org/10.1186/s13045-026-01843-1

Published Online: 2026-09-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lou, Jiacheng https://orcid.org/0000-0003-3109-7266
Lyu, Yizhu
License Information

Text and Data Mining valid from 2026-09-09

Version of Record valid from 2026-09-09
More Information

Article History

Received: 2 August 2026

Accepted: 27 August 2026

First Online: 9 September 2026

Declarations

Ethics approval and consent to participate: Not applicable.

Consent for publication: Not applicable.

Competing interests: The authors declare no competing interests.

Document is current

Any future updates will be listed below